Venture capital velocity: What’s driving renewed momentum in biotech?

As biotech investment reignites, how are venture capitalists responding? Noël Brown, Head of U.S. Biotechnology Investment Banking at RBC Capital Markets, invited three leading investors to share their views of the revived market and the most exciting prospects.